BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shlyankevich J, Chen AJ, Kim GE, Kimball AB. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol. 2014;71:1144-1150. [PMID: 25440440 DOI: 10.1016/j.jaad.2014.09.012] [Cited by in Crossref: 143] [Cited by in F6Publishing: 117] [Article Influence: 20.4] [Reference Citation Analysis]
Number Citing Articles
1 Phan K, Charlton O, Smith SD. Hidradenitis suppurativa and polycystic ovarian syndrome: Systematic review and meta-analysis. Australas J Dermatol 2020;61:e28-33. [PMID: 31261440 DOI: 10.1111/ajd.13110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lim SYD, Oon HH. Systematic review of immunomodulatory therapies for hidradenitis suppurativa. Biologics 2019;13:53-78. [PMID: 31190730 DOI: 10.2147/BTT.S199862] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
3 Perez-Garcia LF, Dolhain R, Te Winkel B, Carrizales JP, Bramer WM, Vorstenbosch S, van Puijenbroek E, Hazes M, van Doorn MBA. Male Sexual Health and Reproduction in Cutaneous Immune-Mediated Diseases: A Systematic Review. Sex Med Rev 2021;9:423-33. [PMID: 32883623 DOI: 10.1016/j.sxmr.2020.07.004] [Reference Citation Analysis]
4 Sherman S, Tzur Bitan D, Kridin K, Pavlovsky L, Hodak E, Cohen AD. Hidradenitis suppurativa is associated with hypothyroidism and hyperthyroidism: a large-scale population-based study. Int J Dermatol 2021;60:321-6. [PMID: 33241580 DOI: 10.1111/ijd.15319] [Reference Citation Analysis]
5 Ingram JR. The epidemiology of hidradenitis suppurativa. Br J Dermatol 2020;183:990-8. [PMID: 32880911 DOI: 10.1111/bjd.19435] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
6 Micheletti R. Tobacco smoking and hidradenitis suppurativa: associated disease and an important modifiable risk factor. Br J Dermatol 2018;178:587-8. [DOI: 10.1111/bjd.16261] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bouazzi D, Chafranska L, Saunte DML, Jemec GBE. Systematic Review of Complications and Recurrences After Surgical Interventions in Hidradenitis Suppurativa. Dermatol Surg 2020;46:914-21. [PMID: 32049703 DOI: 10.1097/DSS.0000000000002323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
8 Adibi N, Robati RM. Skin and metabolic syndrome: A review of the possible associations. J Res Med Sci 2021;26:16. [PMID: 34084195 DOI: 10.4103/jrms.JRMS_585_20] [Reference Citation Analysis]
9 Choi E, Cook AR, Chandran NS. Hidradenitis Suppurativa: An Asian Perspective from a Singaporean Institute. Skin Appendage Disord 2018;4:281-5. [PMID: 30410897 DOI: 10.1159/000481836] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
10 González-López MA, Lacalle M, Mata C, López-Escobar M, Corrales A, López-Mejías R, Rueda J, González-Vela MC, González-Gay MA, Blanco R, Hernández JL. Carotid ultrasound is useful for the cardiovascular risk stratification in patients with hidradenitis suppurativa. PLoS One 2018;13:e0190568. [PMID: 29300768 DOI: 10.1371/journal.pone.0190568] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tzur Bitan D, Berzin D, Cohen A. Hidradenitis suppurativa and schizophrenia: a nationwide cohort study. J Eur Acad Dermatol Venereol 2019;34:574-9. [DOI: 10.1111/jdv.15997] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
12 Damiani G, Leone S, Fajgenbaum K, Bragazzi NL, Pacifico A, Conic RR, Pigatto PD, Maiorana C, Poli P, Berti E, Pace MC, Malagoli P, Bettoli V, Fiore M. Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World J Hepatol 2019;11:391-401. [PMID: 31114643 DOI: 10.4254/wjh.v11.i4.391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
13 Karagiannidis I, Nikolakis G, Zouboulis CC. Endocrinologic Aspects of Hidradenitis Suppurativa. Dermatol Clin 2016;34:45-9. [PMID: 26617357 DOI: 10.1016/j.det.2015.08.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
14 Thorlacius L, Cohen AD, Gislason GH, Jemec GB, Egeberg A. Increased Suicide Risk in Patients with Hidradenitis Suppurativa. Journal of Investigative Dermatology 2018;138:52-7. [DOI: 10.1016/j.jid.2017.09.008] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 23.3] [Reference Citation Analysis]
15 Loget J, Saint-Martin C, Guillem P, Kanagaratnam L, Becherel PA, Nassif A, Fougerousse AC, Siham M, Girard C, Barthelemy H, Chaby G, Gabison G, Perrot JL, Pallure V, Beneton N, Boye T, Jacobzone C, Begon E, Bernard P, Reguiai Z; sous l’égide de « ResoVerneil ». [Misdiagnosis of hidradenitis suppurativa continues to be a major issue. The R-ENS Verneuil study]. Ann Dermatol Venereol 2018;145:331-8. [PMID: 29704958 DOI: 10.1016/j.annder.2018.01.043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
16 Jung JM, Lee KH, Kim YJ, Chang SE, Lee MW, Choi JH, Won CH, Lee WJ. Assessment of Overall and Specific Cancer Risks in Patients With Hidradenitis Suppurativa. JAMA Dermatol 2020;156:844-53. [PMID: 32459291 DOI: 10.1001/jamadermatol.2020.1422] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
17 Mehdizadeh A, Rosella L, Alavi A, Sibbald G, Farzanfar D, Hazrati A, Vernich L, Laporte A, Hu H, Bashash M. A Canadian Population-Based Cohort to the Study Cost and Burden of Surgically Resected Hidradenitis Suppurativa. J Cutan Med Surg 2018;22:312-7. [PMID: 29528753 DOI: 10.1177/1203475418763536] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
18 Roth MM, Leader N, Kroumpouzos G. Gynecologic and andrologic dermatology and the metabolic syndrome. Clin Dermatol 2018;36:72-80. [PMID: 29241756 DOI: 10.1016/j.clindermatol.2017.09.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
19 Tannenbaum R, Strunk A, Garg A. Association Between Hidradenitis Suppurativa and Lymphoma. JAMA Dermatol 2019;155:624-5. [PMID: 30698627 DOI: 10.1001/jamadermatol.2018.5230] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
20 Ergun T. Hidradenitis suppurativa and the metabolic syndrome. Clin Dermatol 2018;36:41-7. [PMID: 29241751 DOI: 10.1016/j.clindermatol.2017.09.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
21 Theut Riis P, Thorlacius LR, Jemec GB. Investigational drugs in clinical trials for Hidradenitis Suppurativa. Expert Opin Investig Drugs 2018;27:43-53. [PMID: 29188733 DOI: 10.1080/13543784.2018.1412430] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
22 González-López MA, Ocejo-Viñals JG, Mata C, Díaz D, Guiral S, Portilla V, Corrales A, González-Vela MC, González-Gay MA, Blanco R, Hernández JL. Evaluation of serum omentin-1 and apelin concentrations in patients with hidradenitis suppurativa. Postepy Dermatol Alergol 2021;38:450-4. [PMID: 34377127 DOI: 10.5114/ada.2021.107932] [Reference Citation Analysis]
23 Alikhan A, Sayed C, Alavi A, Alhusayen R, Brassard A, Burkhart C, Crowell K, Eisen DB, Gottlieb AB, Hamzavi I, Hazen PG, Jaleel T, Kimball AB, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol 2019;81:76-90. [PMID: 30872156 DOI: 10.1016/j.jaad.2019.02.067] [Cited by in Crossref: 77] [Cited by in F6Publishing: 51] [Article Influence: 38.5] [Reference Citation Analysis]
24 Andrade TCPC, Vieira BC, Oliveira AMN, Martins TY, Santiago TM, Martelli ACC. Hidradenitis suppurativa: epidemiological study of cases diagnosed at a dermatological reference center in the city of Bauru, in the Brazilian southeast State of São Paulo, between 2005 and 2015. An Bras Dermatol 2017;92:196-9. [PMID: 28538878 DOI: 10.1590/abd1806-4841.20175588] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
25 Napolitano M, Megna M, Timoshchuk EA, Patruno C, Balato N, Fabbrocini G, Monfrecola G. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol 2017;10:105-15. [PMID: 28458570 DOI: 10.2147/CCID.S111019] [Cited by in Crossref: 80] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
26 Ahmad Kamil MA, Mohd Affandi A. Hidradenitis Suppurativa in Kuala Lumpur, Malaysia: A 7-Year Retrospective Review. Dermatol Res Pract 2018;2018:2017959. [PMID: 29951091 DOI: 10.1155/2018/2017959] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
27 Lima AL, Karl I, Giner T, Poppe H, Schmidt M, Presser D, Goebeler M, Bauer B. Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa. Br J Dermatol. 2016;174:514-521. [PMID: 26436522 DOI: 10.1111/bjd.14214] [Cited by in Crossref: 111] [Cited by in F6Publishing: 92] [Article Influence: 18.5] [Reference Citation Analysis]
28 Wark KJL, Cains GD. The Microbiome in Hidradenitis Suppurativa: A Review. Dermatol Ther (Heidelb) 2021;11:39-52. [PMID: 33244661 DOI: 10.1007/s13555-020-00465-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
29 Marvel J, Vlahiotis A, Sainski-Nguyen A, Willson T, Kimball A. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data. BMJ Open 2019;9:e030579. [PMID: 31575575 DOI: 10.1136/bmjopen-2019-030579] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
30 Fisher S, Jehassi A, Ziv M. Hidradenitis suppurativa on Facebook: thematic and content analyses of patient support group. Arch Dermatol Res 2020;312:421-6. [PMID: 31845011 DOI: 10.1007/s00403-019-02027-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
31 Bui T, Silva-hirschberg C, Torres J, Armstrong AW. Hidradenitis suppurativa and diabetes mellitus: A systematic review and meta-analysis. Journal of the American Academy of Dermatology 2018;78:395-402. [DOI: 10.1016/j.jaad.2017.08.042] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
32 Tiri H, Jokelainen J, Timonen M, Tasanen K, Huilaja L. Somatic and psychiatric comorbidities of hidradenitis suppurativa in children and adolescents. Journal of the American Academy of Dermatology 2018;79:514-9. [DOI: 10.1016/j.jaad.2018.02.067] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 8.7] [Reference Citation Analysis]
33 Scuderi N, Monfrecola A, Dessy LA, Fabbrocini G, Megna M, Monfrecola G. Medical and Surgical Treatment of Hidradenitis Suppurativa: A Review. Skin Appendage Disord 2017;3:95-110. [PMID: 28560220 DOI: 10.1159/000462979] [Cited by in Crossref: 24] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
34 Tzellos T, Zouboulis C, Gulliver W, Cohen A, Wolkenstein P, Jemec G. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies. Br J Dermatol 2015;173:1142-55. [DOI: 10.1111/bjd.14024] [Cited by in Crossref: 74] [Cited by in F6Publishing: 64] [Article Influence: 12.3] [Reference Citation Analysis]
35 Lee A, Fischer G. A case series of 20 women with hidradenitis suppurativa treated with spironolactone. Australas J Dermatol 2015;56:192-6. [PMID: 26080895 DOI: 10.1111/ajd.12362] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
36 Wertenteil S, Strunk A, Garg A. Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa. J Am Acad Dermatol 2019;80:1308-13. [PMID: 30287328 DOI: 10.1016/j.jaad.2018.09.040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
37 Choi F, Lehmer L, Ekelem C, Mesinkovska NA. Dietary and metabolic factors in the pathogenesis of hidradenitis suppurativa: a systematic review. Int J Dermatol 2020;59:143-53. [PMID: 31651051 DOI: 10.1111/ijd.14691] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
38 Mclellan C, Sisic M, Oon HH, Tan J. Preliminary Validation of the HS-QoL: A Quality-of-Life Measure for Hidradenitis Suppurativa. J Cutan Med Surg 2018;22:142-6. [DOI: 10.1177/1203475417736281] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
39 Connor CJ. Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines. Clin Cosmet Investig Dermatol 2017;10:117-32. [PMID: 28458571 DOI: 10.2147/CCID.S111041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
40 Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa. Journal of the American Academy of Dermatology 2020;82:1045-58. [DOI: 10.1016/j.jaad.2019.08.090] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 35.0] [Reference Citation Analysis]
41 Jørgensen A, Yao Y, Ghazanfar M, Ring H, Thomsen S. Burden, predictors and temporal relationships of comorbidities in patients with hidradenitis suppurativa: a hospital‐based cohort study. J Eur Acad Dermatol Venereol 2019;34:565-73. [DOI: 10.1111/jdv.15904] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
42 Deckers IE, Kimball AB. The Handicap of Hidradenitis Suppurativa. Dermatologic Clinics 2016;34:17-22. [DOI: 10.1016/j.det.2015.07.003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
43 Andersen RK, Jemec GB. Treatments for hidradenitis suppurativa. Clin Dermatol 2017;35:218-24. [PMID: 28274363 DOI: 10.1016/j.clindermatol.2016.10.018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 5.2] [Reference Citation Analysis]
44 Chiricozzi A, Giovanardi G, Caposiena Caro DR, Iannone M, De Simone C, Cannizzaro MV, Oranges T, Fossati B, Di Matteo E, Dini V, Bianchi L, Peris K. Characterization of comorbid conditions burdening hidradenitis suppurativa: a multicentric observational study. G Ital Dermatol Venereol 2020;155. [DOI: 10.23736/s0392-0488.18.06165-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Stefanadi EC, Dimitrakakis G, Antoniou CK, Challoumas D, Punjabi N, Dimitrakaki IA, Punjabi S, Stefanadis CI. Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients. Diabetol Metab Syndr 2018;10:9. [PMID: 29483947 DOI: 10.1186/s13098-018-0311-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
46 Garg A, Birabaharan M, Strunk A. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States. Journal of the American Academy of Dermatology 2018;79:71-6. [DOI: 10.1016/j.jaad.2018.01.014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
47 Garg A, Wertenteil S, Baltz R, Strunk A, Finelt N. Prevalence Estimates for Hidradenitis Suppurativa among Children and Adolescents in the United States: A Gender- and Age-Adjusted Population Analysis. Journal of Investigative Dermatology 2018;138:2152-6. [DOI: 10.1016/j.jid.2018.04.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
48 Garg A, Lavian J, Lin G, Strunk A, Alloo A. Incidence of hidradenitis suppurativa in the United States: A sex- and age-adjusted population analysis. Journal of the American Academy of Dermatology 2017;77:118-22. [DOI: 10.1016/j.jaad.2017.02.005] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 18.0] [Reference Citation Analysis]
49 Wright S, Strunk A, Garg A. New-onset depression among children, adolescents, and adults with hidradenitis suppurativa. Journal of the American Academy of Dermatology 2020;83:1360-6. [DOI: 10.1016/j.jaad.2020.05.090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
50 Colosimo C, Yon JR, Fredericks C, Kingsley S, Gupta S, Mentzer CJ, Bokhari F, Poulakidas S. Obesity is Not Associated With Need for Skin Grafting After Hidradenitis Excision. Am Surg 2021;87:458-62. [PMID: 33047967 DOI: 10.1177/0003134820950686] [Reference Citation Analysis]
51 Saraç Öztürk G, Ergun T, Peker Eyüboğlu İ, Akkiprik M. Serum high-sensitivity C-reactive protein, tumor necrosis factor-α, interleukin (IL)-1β, IL-17A and IL-23 levels in patients with hidradenitis suppurativa. Cytokine 2021;144:155585. [PMID: 34034145 DOI: 10.1016/j.cyto.2021.155585] [Reference Citation Analysis]
52 Shalom G, Freud T, Harman‐boehm I, Polishchuk I, Cohen A. Hidradenitis suppurativa and metabolic syndrome: a comparative cross‐sectional study of 3207 patients. Br J Dermatol 2015;173:464-70. [DOI: 10.1111/bjd.13777] [Cited by in Crossref: 85] [Cited by in F6Publishing: 74] [Article Influence: 14.2] [Reference Citation Analysis]
53 Garg A, Papagermanos V, Midura M, Strunk A. Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U.S.A. Br J Dermatol. 2018;178:709-714. [PMID: 28960235 DOI: 10.1111/bjd.15939] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 13.0] [Reference Citation Analysis]
54 Jemec GBE, Okun MM, Forman SB, Gulliver WPF, Prens EP, Mrowietz U, Armstrong AW, Geng Z, Gu Y, Williams DA, Teixeira HD, Kimball AB. Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials. Br J Dermatol 2019;181:967-75. [PMID: 30916379 DOI: 10.1111/bjd.17919] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
55 Ingram JR, Jenkins-Jones S, Knipe DW, Morgan CLI, Cannings-John R, Piguet V. Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa. Br J Dermatol. 2018;178:917-924. [PMID: 29094346 DOI: 10.1111/bjd.16101] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 25.0] [Reference Citation Analysis]
56 Wehner MR, Micheletti R, Noe MH, Linos E, Margolis DJ, Naik HB. Hidradenitis suppurativa encounters in a national electronic health record database notable for low dermatology utilization, infrequent biologic prescriptions, and frequent opiate prescriptions. J Am Acad Dermatol 2020;82:1239-41. [PMID: 31866261 DOI: 10.1016/j.jaad.2019.12.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Marasca C, Napolitano M, Monfrecola G, Masarà A, Annunziata MC, Donnarumma M, Fabbrocini G. Quality of life in people living with patients suffering from hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2020;34:e342-3. [PMID: 32118320 DOI: 10.1111/jdv.16319] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
58 Shalom G, Babaev M, Freud T, Tiosano S, Pam N, Horev A, Dreiher J, Vardy DA, Comaneshter D, Cohen AD. Demographic and health care service utilization by 4417 patients with hidradenitis suppurativa. J Am Acad Dermatol 2017;77:1047-1052.e2. [PMID: 28989106 DOI: 10.1016/j.jaad.2017.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
59 Smith MK, Nicholson CL, Parks-Miller A, Hamzavi IH. Hidradenitis suppurativa: an update on connecting the tracts. F1000Res. 2017;6:1272. [PMID: 28794864 DOI: 10.12688/f1000research.11337.1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
60 Wollina U, Langner D, Heinig B, Nowak A. Comorbidities, treatment, and outcome in severe anogenital inverse acne (hidradenitis suppurativa): a 15-year single center report. Int J Dermatol 2017;56:109-15. [PMID: 27495143 DOI: 10.1111/ijd.13393] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
61 Rondags A, Arends S, Wink FR, Horváth B, Spoorenberg A. High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation. Semin Arthritis Rheum 2019;48:611-7. [PMID: 29751976 DOI: 10.1016/j.semarthrit.2018.03.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
62 Matusiak Ł. Profound consequences of hidradenitis suppurativa: a review. Br J Dermatol 2020;183:e171-7. [PMID: 29744872 DOI: 10.1111/bjd.16603] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
63 Prens EP, Lugo-Somolinos AM, Paller AS, Kerdel F, Duan Y, Teixeira HD, Longcore M, Kimball AB. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice. Am J Clin Dermatol 2020;21:579-90. [PMID: 32077014 DOI: 10.1007/s40257-020-00504-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
64 Vekic DA, Frew J, Cains GD. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1. Australas J Dermatol 2018;59:267-77. [PMID: 29355905 DOI: 10.1111/ajd.12770] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
65 Huilaja L, Tiri H, Jokelainen J, Timonen M, Tasanen K. Patients with Hidradenitis Suppurativa Have a High Psychiatric Disease Burden: A Finnish Nationwide Registry Study. Journal of Investigative Dermatology 2018;138:46-51. [DOI: 10.1016/j.jid.2017.06.020] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
66 Lee J, Kwon H, Jung H, Kim G, Bae J. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study. J Eur Acad Dermatol Venereol 2018;32:1784-90. [DOI: 10.1111/jdv.15071] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 14.7] [Reference Citation Analysis]
67 Edigin E, Kaul S, Eseaton PO. Analysis of hidradenitis suppurativa hospitalizations: A report from the National Inpatient Sample database. J Am Acad Dermatol 2020:S0190-9622(20)32904-2. [PMID: 33152368 DOI: 10.1016/j.jaad.2020.10.083] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
68 Cartron A, Driscoll MS. Comorbidities of hidradenitis suppurativa: A review of the literature. Int J Womens Dermatol 2019;5:330-4. [PMID: 31909152 DOI: 10.1016/j.ijwd.2019.06.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
69 Phan K, Huo YR, Smith SD. Hidradenitis suppurativa and psychiatric comorbidities, suicides and substance abuse: systematic review and meta-analysis. Ann Transl Med 2020;8:821. [PMID: 32793666 DOI: 10.21037/atm-20-1028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Misitzis A, Goldust M, Jafferany M, Lotti T. Psychiatric comorbidities in patients with hidradenitis suppurativa. Dermatologic Therapy 2020;33. [DOI: 10.1111/dth.13541] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
71 Sisic M, Kirby JS, Boyal S, Plant L, McLellan C, Tan J. Development of a Quality-of-Life Measure for Hidradenitis Suppurativa. J Cutan Med Surg 2017;21:152-5. [PMID: 27837158 DOI: 10.1177/1203475416677721] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
72 Storer MA, Danesh MJ, Sandhu ME, Pascoe V, Kimball AB. An assessment of the relative impact of hidradenitis suppurativa, psoriasis, and obesity on quality of life. Int J Womens Dermatol 2018;4:198-202. [PMID: 30627617 DOI: 10.1016/j.ijwd.2018.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
73 Loo CH, Tan WC, Tang JJ, Khor YH, Manikam MT, Low D, Chan KH, Chan KH, Teoh YM, Sohot NQA, Tang MM, Chan LC. The clinical, biochemical, and ultrasonographic characteristics of patients with hidradenitis suppurativa in Northern Peninsular Malaysia: a multicenter study. Int J Dermatol 2018;57:1454-63. [DOI: 10.1111/ijd.14210] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
74 Misitzis A, Cunha PR, Kroumpouzos G. Skin disease related to metabolic syndrome in women. Int J Womens Dermatol 2019;5:205-12. [PMID: 31700973 DOI: 10.1016/j.ijwd.2019.06.030] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
75 Hasan SB, Smith SP, Brain A, Mohd Mustapa MF, Cheung ST, Ingram JR, de Berker DAR. British Association of Dermatologists National Clinical Audit on the Management of Hidradenitis Suppurativa in the UK. Clin Exp Dermatol 2021;46:1023-7. [PMID: 33577133 DOI: 10.1111/ced.14598] [Reference Citation Analysis]
76 Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, Sirna R, Gisondi P, Patrizi A, Dini V, Bianchini D, Bianchi L, Fania L, Prignano F, Offidani A, Atzori L, Bettoli V, Cannavò SP, Venturini M, Bongiorno MR, Costanzo A, Fabbrocini G, Peris K. Evidence for a 'window of opportunity' in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study. Br J Dermatol 2021;184:133-40. [PMID: 32119111 DOI: 10.1111/bjd.18983] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 21.0] [Reference Citation Analysis]
77 Garg A, Malviya N, Strunk A, Wright S, Alavi A, Alhusayen R, Alikhan A, Daveluy SD, Delorme I, Goldfarb N, Gulliver W, Hamzavi I, Jaleel T, Kimball AB, Kirby JS, Kirchhof MG, Lester J, Lev-Tov H, Lowes MA, Micheletti R, Orenstein LA, Piguet V, Sayed C, Tan J, Naik HB. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol 2021:S0190-9622(21)00213-9. [PMID: 33493574 DOI: 10.1016/j.jaad.2021.01.059] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
78 Hallock KK, Mizerak MR, Dempsey A, Maczuga S, Kirby JS. Differences Between Children and Adults With Hidradenitis Suppurativa. JAMA Dermatol 2021. [PMID: 34379074 DOI: 10.1001/jamadermatol.2021.2865] [Reference Citation Analysis]
79 Patel KR, Lee HH, Rastogi S, Vakharia PP, Hua T, Chhiba K, Singam V, Silverberg JI. Association between hidradenitis suppurativa, depression, anxiety, and suicidality: A systematic review and meta-analysis. Journal of the American Academy of Dermatology 2020;83:737-44. [DOI: 10.1016/j.jaad.2019.11.068] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
80 Garg A, Papagermanos V, Midura M, Strunk A, Merson J. Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States. Journal of the American Academy of Dermatology 2018;79:495-500.e1. [DOI: 10.1016/j.jaad.2018.02.053] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 13.0] [Reference Citation Analysis]
81 Mavrogiorgou P, Juckel G, Reimelt A, Hessam S, Scholl L, Frajkur JL, Stockfleth E, Bechara FG. [Psychiatric comorbidities in hidradenitis suppurativa/acne inversa]. Hautarzt 2021;72:426-34. [PMID: 33398389 DOI: 10.1007/s00105-020-04742-9] [Reference Citation Analysis]
82 Chandran NS, Lee JH, Kurokawa I. Hidradenitis suppurativa in South-East Asia and East Asia. Exp Dermatol 2021;30 Suppl 1:23-6. [PMID: 34085331 DOI: 10.1111/exd.14340] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
83 Denny G, Anadkat MJ. The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study. J Am Acad Dermatol 2017;76:54-9. [PMID: 27692736 DOI: 10.1016/j.jaad.2016.07.041] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
84 Dessinioti C, Plaka M, Zisimou C, Christofidou E, Antoniou C, Stratigos A. Advanced squamous cell carcinoma of the axillae mimicking hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2017;31:e421-3. [DOI: 10.1111/jdv.14235] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
85 Loo CH, Khoo ACH, Tan WC, Khor YH, Tang JJ, Tang MM, Chan LC. The findings of 18F-fluorodeoxyglucose positron emission tomography-computed tomography scan in patients with hidradenitis suppurativa in Malaysia: A multicenter study. World J Nucl Med 2021;20:32-7. [PMID: 33850487 DOI: 10.4103/wjnm.WJNM_33_20] [Reference Citation Analysis]
86 Garg A, Hundal J, Strunk A. Overall and Subgroup Prevalence of Crohn Disease Among Patients With Hidradenitis Suppurativa: A Population-Based Analysis in the United States. JAMA Dermatol. 2018;154:814-818. [PMID: 29800049 DOI: 10.1001/jamadermatol.2018.0878] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 11.5] [Reference Citation Analysis]
87 Sachdeva M, Shah M, Alavi A. Race-Specific Prevalence of Hidradenitis Suppurativa. J Cutan Med Surg 2021;25:177-87. [DOI: 10.1177/1203475420972348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
88 Sabat R, Jemec GBE, Matusiak Ł, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers 2020;6:18. [PMID: 32165620 DOI: 10.1038/s41572-020-0149-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 56.0] [Reference Citation Analysis]
89 Desai N, Shah P. High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics. Br J Dermatol 2017;176:1048-55. [DOI: 10.1111/bjd.14976] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
90 Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States. JAMA Dermatol 2017;153:760-4. [PMID: 28492923 DOI: 10.1001/jamadermatol.2017.0201] [Cited by in Crossref: 127] [Cited by in F6Publishing: 102] [Article Influence: 31.8] [Reference Citation Analysis]
91 Tugnoli S, Agnoli C, Silvestri A, Giari S, Bettoli V, Caracciolo S. Anger, Emotional Fragility, Self-esteem, and Psychiatric Comorbidity in Patients with Hidradenitis Suppurativa/Acne Inversa. J Clin Psychol Med Settings 2020;27:527-40. [DOI: 10.1007/s10880-019-09640-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
92 Jfri A, Litvinov IV, Netchiporouk E, O'Brien E. Clinical and psychosocial factors affecting work productivity among patients with hidradenitis suppurativa: A cluster analytical investigation. J Am Acad Dermatol 2021:S0190-9622(21)00461-8. [PMID: 33662462 DOI: 10.1016/j.jaad.2021.02.066] [Reference Citation Analysis]
93 Argyropoulou M, Kanni T, Kyprianou M, Melachroinopoulos N, Giamarellos‐bourboulis E. Cost‐savings of adalimumab in hidradenitis suppurativa: a retrospective analysis of a real‐world cohort. Br J Dermatol 2019;180:1161-8. [DOI: 10.1111/bjd.17151] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
94 Karagiannidis I, Nikolakis G, Sabat R, Zouboulis CC. Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder? Rev Endocr Metab Disord 2016;17:335-41. [DOI: 10.1007/s11154-016-9366-z] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
95 Nguyen T, Damiani G, Orenstein L, Hamzavi I, Jemec G. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol 2021;35:50-61. [DOI: 10.1111/jdv.16677] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 23.0] [Reference Citation Analysis]
96 Martorell A, García-martínez F, Jiménez-gallo D, Pascual J, Pereyra-rodriguez J, Salgado L, Vilarrasa E. Actualización en hidradenitis supurativa (I): epidemiología, aspectos clínicos y definición de severidad de la enfermedad. Actas Dermo-Sifiliográficas 2015;106:703-15. [DOI: 10.1016/j.ad.2015.06.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 6.8] [Reference Citation Analysis]
97 Melnik BC, John SM, Chen W, Plewig G. T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities. Br J Dermatol 2018;179:260-72. [PMID: 29573406 DOI: 10.1111/bjd.16561] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
98 Veysey EC. Hidradenitis suppurativa and the metabolic syndrome. Br J Dermatol 2015;173:325-6. [PMID: 26346081 DOI: 10.1111/bjd.13902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
99 Molinelli E, Sapigni C, Campanati A, Brisigotti V, Offidani A. Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa. Expert Opin Drug Metab Toxicol 2020;16:1019-37. [PMID: 32896186 DOI: 10.1080/17425255.2020.1810233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Dauden E, Lazaro P, Aguilar M, Blasco A, Suarez C, Marin I, Queiro R, Bassas-vila J, Martorell A, García-campayo J. Recommendations for the management of comorbidity in hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2018;32:129-44. [DOI: 10.1111/jdv.14517] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
101 Wright S, Strunk A, Garg A. Trends in body mass index before and after diagnosis of hidradenitis suppurativa. Br J Dermatol 2021;185:74-9. [DOI: 10.1111/bjd.19713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 González-lópez MA, Hernández JL, Vilanova I, Mata C, López-escobar M, González-vela MC, López-hoyos M, González-gay MA, Blanco R. Thyroid autoimmunity in patients with hidradenitis suppurativa: a case-control study. Clin Exp Dermatol 2017;42:642-4. [DOI: 10.1111/ced.13153] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
103 Phan K, Charlton O, Smith SD. Hidradenitis suppurativa and diabetes mellitus: updated systematic review and adjusted meta-analysis. Clin Exp Dermatol 2019;44:e126-32. [PMID: 30730068 DOI: 10.1111/ced.13922] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
104 Pektas SD, Cinar N, Duman DD, Kara A, Batu J, Karakas-Celik S, Aksoy DY. The relationship among androgens, insulin resistance and ghrelin polymorphisms in post-adolescent male patients with severe acne vulgaris. Postepy Dermatol Alergol 2020;37:800-9. [PMID: 33240024 DOI: 10.5114/ada.2020.100492] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
105 Phan K, Huo YR, Charlton O, Smith SD. Hidradenitis Suppurativa and Thyroid Disease: Systematic Review and Meta-Analysis. J Cutan Med Surg 2020;24:23-7. [DOI: 10.1177/1203475419874411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
106 Garg A, Neuren E, Strunk A. Hidradenitis Suppurativa Is Associated with Polycystic Ovary Syndrome: A Population-Based Analysis in the United States. Journal of Investigative Dermatology 2018;138:1288-92. [DOI: 10.1016/j.jid.2018.01.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
107 Garg A, Strunk A, Midura M, Papagermanos V, Pomerantz H. Prevalence of hidradenitis suppurativa among patients with Down syndrome: a population-based cross-sectional analysis. Br J Dermatol 2018;178:697-703. [DOI: 10.1111/bjd.15770] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
108 González-López MA, Hernández JL, Lacalle M, Mata C, López-Escobar M, López-Mejías R, Portilla V, Fuentevilla P, Corrales A, González-Vela MC, González-Gay MA, Blanco R. Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS). J Am Acad Dermatol 2016;75:329-35. [PMID: 27287248 DOI: 10.1016/j.jaad.2016.03.025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
109 Abdel Azim AA, Salem RT, Abdelghani R. Combined fractional carbon dioxide laser and long-pulsed neodymium : yttrium-aluminium-garnet (1064 nm) laser in treatment of hidradenitis suppurativa; a prospective randomized intra-individual controlled study. Int J Dermatol 2018;57:1135-44. [DOI: 10.1111/ijd.14075] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
110 Vilanova I, Hernández JL, Mata C, Durán C, García-Unzueta MT, Portilla V, Fuentevilla P, Corrales A, González-Vela MC, González-Gay MA, Blanco R, González-López MA. Insulin resistance in hidradenitis suppurativa: a case-control study. J Eur Acad Dermatol Venereol 2018;32:820-4. [PMID: 29485215 DOI: 10.1111/jdv.14894] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 10.7] [Reference Citation Analysis]
111 Liy-Wong C, Kim M, Kirkorian AY, Eichenfield LF, Diaz LZ, Horev A, Tollefson M, Oranges T, Philips R, Chiu YE, Ghafari G, Arnold JD, Sprague J, Nguyen H, Wan S, Atenafu EG, Pope E, Hamilton J, Naik HB, Lara-Corrales I. Hidradenitis Suppurativa in the Pediatric Population: An International, Multicenter, Retrospective, Cross-sectional Study of 481 Pediatric Patients. JAMA Dermatol 2021;157:385-91. [PMID: 33625473 DOI: 10.1001/jamadermatol.2020.5435] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
112 Kohorst JJ, Kimball AB, Davis MD. Systemic associations of hidradenitis suppurativa. J Am Acad Dermatol 2015;73:S27-35. [PMID: 26470611 DOI: 10.1016/j.jaad.2015.07.055] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 15.6] [Reference Citation Analysis]
113 Riis PT, Søeby K, Saunte DM, Jemec GBE. Patients with hidradenitis suppurativa carry a higher systemic inflammatory load than other dermatological patients. Arch Dermatol Res 2015;307:885-9. [DOI: 10.1007/s00403-015-1596-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
114 Hayran Y, Allı N, Yücel Ç, Akdoğan N, Turhan T. Serum IL-36α, IL-36β, and IL-36γ levels in patients with hidradenitis suppurativa: association with disease characteristics, smoking, obesity, and metabolic syndrome. Arch Dermatol Res 2020;312:187-96. [DOI: 10.1007/s00403-019-02012-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
115 Chang JE, Choi MS. A Molecular Perspective on the Potential Benefits of Metformin for the Treatment of Inflammatory Skin Disorders. Int J Mol Sci 2020;21:E8960. [PMID: 33255783 DOI: 10.3390/ijms21238960] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
116 Kluger N, Ranta M, Serlachius M. The Burden of Hidradenitis Suppurativa in a Cohort of Patients in Southern Finland: A Pilot Study. Skin Appendage Disord 2017;3:20-7. [PMID: 28611997 DOI: 10.1159/000455236] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
117 Vural S, Gündoğdu M, Akay BN, Boyvat A, Erdem C, Koçyiğit P, Bostancı S, Sanli H, Kundakci N. Hidradenitis suppurativa: Clinical characteristics and determinants of treatment efficacy. Dermatologic Therapy 2019;32. [DOI: 10.1111/dth.13003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]